About this Journal Submit a Manuscript Table of Contents
Prostate Cancer
Volume 2013 (2013), Article ID 398253, 7 pages
http://dx.doi.org/10.1155/2013/398253
Research Article

Skip Regulates TGF-β1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer Cells

1Laboratorio de Biología Celular, Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, 7810000 Santiago, Chile
2Department of Biology, University of the Balearic Islands, Ctra Valldemossa, Km 7.5 , 07122 Palma de Mallorca, Spain
3Laboratory for Experimental Haematology and Stem Cells, Institute for Medical Research, University of Belgrade, Dr. Subotica 4, P.O. Box 102, 11129 Belgrade, Serbia

Received 19 February 2013; Revised 25 April 2013; Accepted 29 April 2013

Academic Editor: Fazlul H. Sarkar

Copyright © 2013 Victor Villar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Padua and J. Massagué, “Roles of TGFbeta in metastasis,” Cell Research, vol. 19, pp. 89–102, 2009.
  2. P. Wikstrom, P. Stattin, I. Franck-Lissbrant, J. E. Damber, and A. Bergh, “Transforming growth factor B1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer,” Prostate, vol. 37, pp. 19–29, 1998.
  3. N. Sidenius and F. Blasi, “The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy,” Cancer and Metastasis Reviews, vol. 22, no. 2-3, pp. 205–222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. K. Durand, J. S. Bodker, A. Christensen, et al., “Plasminogen activator inhibitor-1 and tumor growth, invasion, and metastasis,” Thrombosis and Haemostasis, vol. 91, pp. 439–449, 2004.
  5. E. I. Deryugina and J. P. Quigley, “Matrix metalloproteinases and tumor metastasis,” Cancer and Metastasis Reviews, vol. 25, no. 1, pp. 9–34, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Dass, A. Ahmad, A. S. Azmi, S. H. Sarkar, and F. H. Sarkar, “Evolving role of uPA/uPAR system in human cancers,” Cancer Treatment Reviews, vol. 34, no. 2, pp. 122–136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Festuccia, M. Bologna, C. Vicentini, et al., “Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells,” International Journal of Cancer, vol. 69, pp. 386–393, 1996.
  8. P. J. Van Veldhuizen, R. Sadasivan, R. Cherian, and A. Wyatt, “Urokinase-type plasminogen activator expression in human prostate carcinomas,” American Journal of the Medical Sciences, vol. 312, no. 1, pp. 8–11, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Festuccia, A. Angelucci, G. L. Gravina et al., “Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells,” International Journal of Cancer, vol. 85, pp. 407–415, 2000.
  10. L. Konrad, J. A. Scheiber, L. Schwarz, A. J. Schrader, and R. Hofmann, “TGF-β1 and TGF-β2 strongly enhance the secretion of plasminogen activator inhibitor-1 and matrix metalloproteinase-9 of the human prostate cancer cell line PC-3,” Regulatory Peptides, vol. 155, no. 1–3, pp. 28–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. G. M. Leong, N. Subramaniam, J. Figueroa et al., “Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription,” The Journal of Biological Chemistry, vol. 276, no. 21, pp. 18243–18248, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Folk, F. Půta, and M. Skružný, “Transcriptional coregulator SNW/SKIP: the concealed tie of dissimilar pathways,” Cellular and Molecular Life Sciences, vol. 61, no. 6, pp. 629–640, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Villar, J. Kocic, D. Bugarski, G. Jovcic, and J. F. Santibanez, “SKIP is required for TGF-β1-induced epithelial mesenchymal transition and migration in transformed keratinocytes,” FEBS Letters, vol. 584, no. 22, pp. 4586–4592, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. F. Santibáñez, A. Navarro, and J. Martínez, “Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines,” Anticancer Research, vol. 17, no. 2, pp. 1199–1204, 1997. View at Scopus
  15. J. F. Santibáñez, P. Frontelo, M. Iglesias, J. Martínez, and M. Quintanilla, “Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes,” Journal of Cellular Biochemistry, vol. 74, pp. 61–73, 1999.
  16. J. Francisco Santibáez, J. Guerrero, M. Quintanilla, A. Fabra, and J. Martínez, “Transforming growth factor-β1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes,” Biochemical and Biophysical Research Communications, vol. 296, no. 2, pp. 267–273, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Bello-DeOcampo and D. J. Tindall, “TGF-β/smad signaling in prostate cancer,” Current Drug Targets, vol. 4, no. 3, pp. 197–207, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Kocic, D. Bugarski, and J. F. Santibanez, “SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes,” European Journal of Cancer, vol. 48, pp. 1550–1557, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Koziczak, W. Krek, and Y. Nagamine, “Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1,” Molecular and Cellular Biology, vol. 20, no. 6, pp. 2014–2022, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Y. Yao, Y. Wang, J. An et al., “Mutation analysis of the Smad3 gene in human osteoarthritis,” European Journal of Human Genetics, vol. 11, no. 9, pp. 714–717, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Bonniaud, M. Kolb, T. Galt et al., “Smad3 null mice develop airspace enlargement and are resistant to TGF-β-mediated pulmonary fibrosis,” Journal of Immunology, vol. 173, no. 3, pp. 2099–2108, 2004. View at Scopus